Comparison of clinical outcomes in patients with and without COVID-19 following surgical embolectomy for acute limb ischemia

INTRODUCTION: Acute limb ischemia (ALI) continues to be a threatening and challenging emergency in vascular surgery, despite technological and material advancements, and improper treatment may result in major amputations and mortality. The aim of this review is to compare of clinical outcomes in patients with and without COVID-19 following surgical embolectomy for acute limb ischemia EVIDENCE ACQUISITION: Comparison of clinical outcomes in patients with and without COVID-19 following surgical embolectomy for acute limb ischemia-related books, journals, and articles were used as data sources to answer research questions as part of this study’s library research methodology, which relies on online and offline data sources. Utilizing literature emphasizes fundamentals. Comparison of clinical outcomes in patients with and without COVID-19 after surgical embolectomy, utilizing articles from various sources. The search phrase is “Acute Limb Ischemic AND Covid-19 AND Embolectomy” and “ALI AND SARS-CoV-2 infection AND Embolectomy” and “Ischemic AND COVID-19 AND Revacularization.” The research is a literature review, so article queries are chosen solely on the basis of the articles’ compatibility with the research objectives EVIDENCE SYNTHESIS: We obtained a total of ten articles that met our review criteria. Many articles excluded by the year of publication criteria are out-of-date according to our review method considerations. This is due to the lack of publication of research articles related to the topic of our review. CONCLUSIONS: COVID-19 infection appeared to be a predictor of poor outcomes in vascular diseases requiring operative management. After embolectomy in COVID-19-positive patients had a higher mortality rate, a higher rate of complications, and a higher rate of re-thrombosis and significant amputations.